2BB score and signals
Tenax Therapeutics, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 32 | Low |
| Momentum | 69 | Improving |
| Financial strength | 28 | Weak |
| Quality | 35 | Weak |
| Risk | 80 | High |
Tenax Therapeutics, Inc. (TENX) Stock Score & Signals
Tenax Therapeutics, Inc. (TENX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 29 out of 100.
Company facts
| CEO | Chris Giordano |
| Founded | 1967 |
| Employees | 15 |
| 52-week range | $1.31 – $19.40 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-08 | — | -0.3646 | — | $0.00 |
| 2026-11-10 | — | -0.3672 | — | $0.00 |
| 2026-08-11 | — | -0.3687 | — | $0.00 |
| 2026-05-12 | -0.35 | -0.408 | $0.00 | $0.00 |